Global Nuclear Medicine Market Forecasts 2024 Grow With CAGR Of 7.6%

The worldwide market for Nuclear Medicine is expected to grow at a CAGR of roughly 7.6% over the next five years, will reach 6610 million US$ in 2024, from 4590 million US$ in 2019, according to a new Reserach Report.

Overview of the Nuclear Medicine Market Report:

“Nuclear Medicine, or Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide..”

To read more please visit: http://thenewsmates.com/nuclear-medicine-market-analysis-size-application-analysis-regional-outlook-competitive-strategies-and-forecasts-2024-grow-with-cagr-of-7-6/100845/

Source: THE NEWSMATES